Some of these articles are available as free downloads in this newsletter. I’d encourage you to have a look as they are very exciting pieces of work. I’d be really pleased to receive your feedback on the content in this issue; if you have any ideas for really hot topics that you think we could cover in the Drug Discovery Today: Technology series, I’d be very pleased to hear from you.
Best wishes
Dr. SL Carney, Editor, Drug Discovery Today.
Steve Carney was born in Liverpool, England studied Biochemistry at Liverpool University, obtaining a BSc.(Hons). He then read for a PhD on the Biochemistry and Pathology of Connective Tissue Diseases in Manchester University. On completion of his PhD he moved to the Kennedy Institute of Rheumatology, London 1, where he worked with Professor Helen Muir FRS on the biochemistry of experimental Osteoarthritis. Later, he joined Eli Lilly and Co. where he stayed for 15 years and held a number of positions in Biology R&D, initially in Connective Tissue, but latterly in Neuroscience. He left Lilly in 2002 to take up his present position as Managing Editor, Drug Discovery Today, at Elsevier. He has authored over 40 peer-reviewed articles, written several book chapters and has held a number of patents.